Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2

Abstract Background COVID-19 has mutation capability, and there are no specific drug therapies that are available to fight or inhibit the proteins of this virus. The present study aims to investigate the binding affinity of the bioactive and synthetic compounds with the main protease (Mpro) enzymes...

Full description

Saved in:
Bibliographic Details
Main Authors: Nazim Uddin Emon (Author), Md. Munsur Alam (Author), Irin Akter (Author), Saima Akhter (Author), Anjuman Ara Sneha (Author), Md. Irtiza (Author), Marufa Afroj (Author), Arifa Munni (Author), Masruba Hossen Chowdhury (Author), Summiya Hossain (Author)
Format: Book
Published: SpringerOpen, 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8d4f76a0465f4bebb1b6d59879e0549d
042 |a dc 
100 1 0 |a Nazim Uddin Emon  |e author 
700 1 0 |a Md. Munsur Alam  |e author 
700 1 0 |a Irin Akter  |e author 
700 1 0 |a Saima Akhter  |e author 
700 1 0 |a Anjuman Ara Sneha  |e author 
700 1 0 |a Md. Irtiza  |e author 
700 1 0 |a Marufa Afroj  |e author 
700 1 0 |a Arifa Munni  |e author 
700 1 0 |a Masruba Hossen Chowdhury  |e author 
700 1 0 |a Summiya Hossain  |e author 
245 0 0 |a Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2 
260 |b SpringerOpen,   |c 2021-06-01T00:00:00Z. 
500 |a 10.1186/s43094-021-00275-7 
500 |a 2314-7253 
520 |a Abstract Background COVID-19 has mutation capability, and there are no specific drug therapies that are available to fight or inhibit the proteins of this virus. The present study aims to investigate the binding affinity of the bioactive and synthetic compounds with the main protease (Mpro) enzymes and angiotensin-converting enzyme 2 (ACE 2) by computational approach. PASS prediction, pharmacokinetics, and toxicological properties prediction studies were performed through the Google PASS prediction and Swiss ADME/T website. Besides, molecular docking studies were accomplished by BIOVIA Discovery Studio 2020, UCSF Chimera, and PyRx autodock vina. Results The docking scores were inferred and the selected compounds showed results varying from −3.2 to −9.8 (kcal/mol). Theaflavin scored the highest docking score to the 5REB, 6VW1, and 1R42 enzymes and showed the binding affinity as −6.3 kcal/mol, −9.8 kcal/mol, and −8.6 kcal/mol, respectively. Again, kaempferol showed the best binding affinity to the 7BQY (−7.1 kcal/mol) and 6Y2FB (−6.6 kcal/mol) enzymes. All the chemical constituents showed better probability in action in pass prediction analysis. Besides, no ligands (except theaflavin) have any conflict with Lipinski's rules of five, which authorized the drug probability of these ligands. Conclusion Therefore, the selected compounds could be considered a potential herbal treatment source against SARS-CoV-2. 
546 |a EN 
690 |a SARS-CoV-2 
690 |a Theaflavin 
690 |a Kaempferol 
690 |a Drug targets 
690 |a Molecular docking 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-12 (2021) 
787 0 |n https://doi.org/10.1186/s43094-021-00275-7 
787 0 |n https://doaj.org/toc/2314-7253 
856 4 1 |u https://doaj.org/article/8d4f76a0465f4bebb1b6d59879e0549d  |z Connect to this object online.